Skip to main content
Top
Published in: Pediatric Nephrology 6/2008

01-06-2008 | Original Article

Mesangial hypercellularity in children: presenting features and outcomes

Authors: Douglas M. Silverstein, Randall D. Craver

Published in: Pediatric Nephrology | Issue 6/2008

Login to get access

Abstract

Mesangial hypercellularity (MH), in the absence of sclerosis or immune deposition, was a common finding on renal biopsy in our center. We studied 66 children with predominant MH. Among all patients older than 2.7 years, blood pressure (BP) percentile and glomerular filtration rate (GFR) remained stable. Serum albumin (Alb) trended higher (3.0 ± 0.2 start vs. 3.4 ± 0.2 end g/dl, p = 0.06) and urine protein/creatinine lower (4.2 ± 0.9 start vs. 2.3 ± 0.9 end mg/mg, p = 0.18) at the end of the study period. The proportion with stage 1 CKD remained constant: 94% start vs. 92% end. At end, Alb was lower in patients referred for nephrotic syndrome (NS): 4.4 ± 0.3 hematuria vs. 4.2 ± 0.2 proteinuria vs. 2.8 ± 0.3 NS g/dl, p < 0.05 vs. both. Alb was lower (p = 0.03) and urine protein/creatinine trended higher in patients with diffuse foot-process fusion (FPF). Twenty-five percent of patients with focal FPF developed NS, all had relapses, and 63% were steroid sensitive (SS). All but one with diffuse FPF presented with NS; 86% had relapses (mean 1 year) and 63% were SS. GFR trended higher at the end in those with matrix thickening (mat) (119.6 ± 4.7 no mat vs. 129.1 ± 2.6 mat ml/min per 1.73 m2, p = 0.1). Those without mat were less SS (59% no mat vs. 80% mat) and were more likely to require alkylating agents (Alk) for NS. Among those with positive immunofluorescence (IF), 82% had immunoglobulin M (IgM) alone; those with positive IF were more SS and needed Alk for NS. MH predicts a favorable prognosis. FPF predicts NS and multiple relapses.
Literature
1.
go back to reference Schlondorff D (1987) The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J 1:272–281CrossRef Schlondorff D (1987) The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J 1:272–281CrossRef
2.
go back to reference Hass M (2005) Histology and immunohistology of IgA nephropathy. J Nephrol 18:676–680 Hass M (2005) Histology and immunohistology of IgA nephropathy. J Nephrol 18:676–680
3.
go back to reference Lai KN, Chan LY, Leung JC (2005) Mechanisms of tubulointerstitial injury in IgA nephropathy. Kidney Int (Suppl) 94:S110–S115CrossRef Lai KN, Chan LY, Leung JC (2005) Mechanisms of tubulointerstitial injury in IgA nephropathy. Kidney Int (Suppl) 94:S110–S115CrossRef
4.
go back to reference Coppo R, Amore A (2004) Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 65:1544–1547CrossRef Coppo R, Amore A (2004) Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 65:1544–1547CrossRef
5.
go back to reference Kurogi Y (2003) Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. Med Res Rev 23:15–31CrossRef Kurogi Y (2003) Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. Med Res Rev 23:15–31CrossRef
6.
go back to reference Yung S, Tsang RC, Leung JK, Chan TM (2006) Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti-DNA antibody-induced IL-1beta. Kidney Int 69:272–280CrossRef Yung S, Tsang RC, Leung JK, Chan TM (2006) Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti-DNA antibody-induced IL-1beta. Kidney Int 69:272–280CrossRef
7.
go back to reference Chen M, Wang YY, Zhao MH, Zhang YK, Wang HY (2005) Autoantibodies against glomerular mesangial cells and their target antigens in lupus nephritis. Ren Fail 27:507–513CrossRef Chen M, Wang YY, Zhao MH, Zhang YK, Wang HY (2005) Autoantibodies against glomerular mesangial cells and their target antigens in lupus nephritis. Ren Fail 27:507–513CrossRef
8.
go back to reference Allen WR, Travis LB, Cavallo T, Brouhard BH, Cunningham RJ (1982) Immune deposits and mesangial hypercellularity in minimal change nephrotic syndrome: Clinical relevance. J Pediatr 100:188–191CrossRef Allen WR, Travis LB, Cavallo T, Brouhard BH, Cunningham RJ (1982) Immune deposits and mesangial hypercellularity in minimal change nephrotic syndrome: Clinical relevance. J Pediatr 100:188–191CrossRef
9.
go back to reference Southwest Pediatric Nephrology Study Group (1983) Childhood nephrotic syndrome associated with diffuse mesangial hypercellularity. A report of the Southwest Pediatric Study Group. Kidney Int 23:87–94 Southwest Pediatric Nephrology Study Group (1983) Childhood nephrotic syndrome associated with diffuse mesangial hypercellularity. A report of the Southwest Pediatric Study Group. Kidney Int 23:87–94
10.
go back to reference Habib R, Girardin E, Gagnadoux MF, Hinglais N, Levy M, Broyer M (1988) Immunopathological findings in idiopathic nephrosis: clinical significance of glomerular “immune deposits”. Pediatr Nephrol 2:402–408CrossRef Habib R, Girardin E, Gagnadoux MF, Hinglais N, Levy M, Broyer M (1988) Immunopathological findings in idiopathic nephrosis: clinical significance of glomerular “immune deposits”. Pediatr Nephrol 2:402–408CrossRef
11.
go back to reference International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159–165CrossRef International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159–165CrossRef
12.
go back to reference National High Blood Pressure Education Program Working Group on high blood pressure in children and adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 (2 Suppl):555–576CrossRef National High Blood Pressure Education Program Working Group on high blood pressure in children and adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 (2 Suppl):555–576CrossRef
13.
go back to reference Joh K, Matsuyama N, Kanetsuna Y, Usui N, Hattori M, Yumura W, Aizawa S (1998) Nephrotic syndrome associated with diffuse mesangial hypercellularity: is it a heterogeneous disease entity? Am J Nephrol 18:214–220CrossRef Joh K, Matsuyama N, Kanetsuna Y, Usui N, Hattori M, Yumura W, Aizawa S (1998) Nephrotic syndrome associated with diffuse mesangial hypercellularity: is it a heterogeneous disease entity? Am J Nephrol 18:214–220CrossRef
14.
go back to reference Andal A, Saxena S, Chellani HK, Sharma S (1989) Pure mesangial proliferative glomerulonephritis. Nephron 51:314–319CrossRef Andal A, Saxena S, Chellani HK, Sharma S (1989) Pure mesangial proliferative glomerulonephritis. Nephron 51:314–319CrossRef
15.
go back to reference Fries JWU, Rumpelt H-J, Thoenes W (1987) Alterations of glomerular podocytic processes in immunologically mediated glomerular diseases. Kidney Int 32:742–748CrossRef Fries JWU, Rumpelt H-J, Thoenes W (1987) Alterations of glomerular podocytic processes in immunologically mediated glomerular diseases. Kidney Int 32:742–748CrossRef
16.
go back to reference Powell HR (1976) Relationship between proteinuria and epithelial cell change in minimal lesion glomerulopathy. Nephron 16:310–317CrossRef Powell HR (1976) Relationship between proteinuria and epithelial cell change in minimal lesion glomerulopathy. Nephron 16:310–317CrossRef
17.
go back to reference Bohman S-O, Jarenko G, Bohlin AB, Berg U (1984) Foot process fusion and glomerular filtration rate in minimal change nephrotic syndrome. Kidney Int 25:696–700CrossRef Bohman S-O, Jarenko G, Bohlin AB, Berg U (1984) Foot process fusion and glomerular filtration rate in minimal change nephrotic syndrome. Kidney Int 25:696–700CrossRef
18.
go back to reference Chana RS, Martin J, Rahman EU, Wheeler DC (2003) Monocyte adhesion to mesangial matrix modulates cytokine and metalloproteinase production. Kidney Int 63: 889–898CrossRef Chana RS, Martin J, Rahman EU, Wheeler DC (2003) Monocyte adhesion to mesangial matrix modulates cytokine and metalloproteinase production. Kidney Int 63: 889–898CrossRef
19.
go back to reference Ahmed AK, Haylor JL, El Nahas AM, Johnson TS (2007) Localization of matrix metalloproteinases and their inhibitors in experimental progressive kidney scarring. Kidney Int 71:755–763CrossRef Ahmed AK, Haylor JL, El Nahas AM, Johnson TS (2007) Localization of matrix metalloproteinases and their inhibitors in experimental progressive kidney scarring. Kidney Int 71:755–763CrossRef
20.
go back to reference McLennan SV, Kelly DJ, Schache M, Waltham M, Dy V, Langham RG, Yue DK, Gilbert RE (2007) Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy? Kidney Int 72:481–488CrossRef McLennan SV, Kelly DJ, Schache M, Waltham M, Dy V, Langham RG, Yue DK, Gilbert RE (2007) Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy? Kidney Int 72:481–488CrossRef
21.
go back to reference Myllymäki J, Saha H, Mustonen J, Helin H, and Pastrenack A (2003) IgM nephropathy: clinical picture and long-term prognosis. Am J Kidney Dis 41:343–350CrossRef Myllymäki J, Saha H, Mustonen J, Helin H, and Pastrenack A (2003) IgM nephropathy: clinical picture and long-term prognosis. Am J Kidney Dis 41:343–350CrossRef
22.
go back to reference Saha H, Mustonen J, Pasternack A, Helin H (1989) Clinical follow-up of 54 patients with IgM-nephropathy. Am J Nephrol 9:124–128CrossRef Saha H, Mustonen J, Pasternack A, Helin H (1989) Clinical follow-up of 54 patients with IgM-nephropathy. Am J Nephrol 9:124–128CrossRef
23.
go back to reference Pardo V, Riesgo I, Zilleruelo G, Strauss J (1984) The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome. Am J Kidney Dis 3:264–269CrossRef Pardo V, Riesgo I, Zilleruelo G, Strauss J (1984) The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome. Am J Kidney Dis 3:264–269CrossRef
Metadata
Title
Mesangial hypercellularity in children: presenting features and outcomes
Authors
Douglas M. Silverstein
Randall D. Craver
Publication date
01-06-2008
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 6/2008
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-008-0750-0

Other articles of this Issue 6/2008

Pediatric Nephrology 6/2008 Go to the issue